Variant report
Variant | esv1845389 |
---|---|
Chromosome Location | chr5:106324802-106326299 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201063378 | chr5:106324824-106324825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578004534 | chr5:106324830-106324831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199750852 | chr5:106324831-106324832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537383450 | chr5:106324869-106324870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79189988 | chr5:106324897-106324898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10477876 | chr5:106324907-106324908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542275835 | chr5:106325073-106325074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555603077 | chr5:106325115-106325116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572361620 | chr5:106325242-106325243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556644873 | chr5:106325252-106325253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541038488 | chr5:106325316-106325317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139882439 | chr5:106325463-106325464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564184119 | chr5:106325475-106325476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186383221 | chr5:106325479-106325480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564653490 | chr5:106325514-106325515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374508100 | chr5:106325607-106325608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113104022 | chr5:106325612-106325613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570466996 | chr5:106325655-106325656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563888021 | chr5:106325706-106325707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529478062 | chr5:106325746-106325747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528302684 | chr5:106325802-106325803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549032609 | chr5:106325807-106325808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546768400 | chr5:106325811-106325812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111555233 | chr5:106325873-106325874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189675866 | chr5:106325918-106325919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535425238 | chr5:106325998-106325999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4597952 | chr5:106326086-106326087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72784390 | chr5:106326106-106326107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537328176 | chr5:106326128-106326129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77213904 | chr5:106326187-106326188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371536564 | chr5:106326202-106326203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:106322200-106326800 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr5:106322800-106328200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr5:106323800-106325000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr5:106323800-106336000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr5:106324600-106325400 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr5:106325000-106327000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |